5,6-MDO-DMT

Routes of
administrationSmoking^[1]

ATC code

• None

Onset of actionUnknown^[1]

Duration of actionUnknown^[1]

5,6-MDO-DMT

Clinical data
Routes of administration	Smoking[1]
ATC code	None
Pharmacokinetic data
Onset of action	Unknown[1]
Duration of action	Unknown[1]
Identifiers
IUPAC name 2-(5H-[1,3]dioxolo[4,5-f]indol-7-yl)-N,N-dimethylethanamine
CAS Number	82173-81-7 Y
PubChem CID	13140993
ChemSpider	10524352
UNII	QPJ5N6RF24
ChEMBL	ChEMBL283686
CompTox Dashboard (EPA)	DTXSID101336584
Chemical and physical data
Formula	C13H16N2O2
Molar mass	232.283 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN(C)CCC1=CNC2=CC3=C(C=C21)OCO3
InChI InChI=1S/C13H16N2O2/c1-15(2)4-3-9-7-14-11-6-13-12(5-10(9)11)16-8-17-13/h5-7,14H,3-4,8H2,1-2H3 Key:QHEIGHVZMWJQHB-UHFFFAOYSA-N

5,6-MDO-DMT, or 5,6-methylenedioxy-N,N-dimethyltryptamine, is a lesser-known chemical compound of the tryptamine family.^[1] It is the 5,6-methylenedioxy derivative of dimethyltryptamine (DMT) and is an analogue of 5-MeO-DMT.^[1] In his 1991 book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose as greater than 5 mg smoked and the duration as unknown.^[1] 5,6-MDO-DMT produced no effects whatsoever at a dose of 5 mg smoked.^[1] Higher doses were not assessed.^[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-MDO-DMT.^[1] Its chemical synthesis has been described.^[1] 5,6-MDO-DMT was first described in the scientific literature by Toni B. Kline and colleagues in 1982.^[2]